Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Karavitaki, N, Wass, J
Μορφή:	Conference item
Έκδοση:	2010

Παρόμοια τεκμήρια

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
ανά: Karavitaki, N, κ.ά.
Έκδοση: (2013)

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
ανά: Karavitaki, N, κ.ά.
Έκδοση: (2013)

A macroprolactinoma becoming resistant to cabergoline and developing atypical pathology
ανά: Emilia Sbardella, κ.ά.
Έκδοση: (2016-10-01)

Early Prediction of Long-Term Response to Cabergoline in Patients with Macroprolactinomas
ανά: Youngki Lee, κ.ά.
Έκδοση: (2014-09-01)

Cabergoline therapy for Macroprolactinoma during pregnancy: A case report
ανά: Shahzad Hira, κ.ά.
Έκδοση: (2012-10-01)

The outcome of macroprolactinomas resistant to dopamine agonists
ανά: Coculescu, M, κ.ά.
Έκδοση: (2005)

Efficacy and safety of rapid escalation of cabergoline in comparison to conventional regimen for macroprolactinoma: A prospective, randomized trial
ανά: Ashu Rastogi, κ.ά.
Έκδοση: (2012-01-01)

Clinical Outcome of Invasive Pituitary Prolactinomas Treated with Cabergoline
ανά: Bassam M Flamerz Arkawazi
Έκδοση: (2020-01-01)

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
ανά: Herring, N, κ.ά.
Έκδοση: (2009)

A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
ανά: Soni, A, κ.ά.
Έκδοση: (2008)

Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
ανά: Lambert, K, κ.ά.
Έκδοση: (2017)

Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
ανά: Lambert, K, κ.ά.
Έκδοση: (2017)

Cabergoline-Induced Pneumocephalus Following Treatment for Giant Invasive Macroprolactinoma Presenting With Spontaneous Cerebrospinal Fluid Rhinorrhea
ανά: Souha S Elabd, κ.ά.
Έκδοση: (2018-02-01)

Cabergoline-induced mania in a patient of pituitary microadenoma
ανά: Satyakam Mohapatra, κ.ά.
Έκδοση: (2017-01-01)

An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
ανά: Ali S. Alzahrani, κ.ά.
Έκδοση: (2023-12-01)

Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
ανά: Reddy, R, κ.ά.
Έκδοση: (2011)

A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma
ανά: Michelle Maher, κ.ά.
Έκδοση: (2018-07-01)

Non-adenomatous pituitary tumours.
ανά: Karavitaki, N, κ.ά.
Έκδοση: (2009)

Diagnosis and management of prolactinomas and non-functioning pituitary adenomas.
ανά: Rogers, A, κ.ά.
Έκδοση: (2014)

Nonfunctioning pituitary adenomas: the Oxford experience.
ανά: Wass, J, κ.ά.
Έκδοση: (2009)

Growth hormone replacement in patients with non-functioning pituitary adenoma treated solely by surgery is not associated with increased risk of tumour recurrence.
ανά: Arnold, J, κ.ά.
Έκδοση: (2008)

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
ανά: Arnold, JR, κ.ά.
Έκδοση: (2009)

The postoperative monitoring of nonfunctioning pituitary adenomas.
ανά: Wass, J, κ.ά.
Έκδοση: (2011)

The postoperative monitoring of nonfunctioning pituitary adenomas
ανά: Wass, J, κ.ά.
Έκδοση: (2011)

Treatment of pituitary tumors: history.
ανά: Thanabalasingham, G, κ.ά.
Έκδοση: (2005)

VISUAL FIELD DEFECTS SECONDARY TO CABERGOLINE USE IN A PATIENT WITH PITUITARY TUMOR
ανά: sylvia andrea araneda, κ.ά.
Έκδοση: (2015-02-01)

Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction
ανά: Pankaj Agrawal, κ.ά.
Έκδοση: (2022-12-01)

Efficacy of cabergoline therapy in patients with non-functioning pituitary adenomas: A single center clinical experience
ανά: Guadalupe Vargas-Ortega, κ.ά.
Έκδοση: (2022-07-01)

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline
ανά: Emre Bozkirli, κ.ά.
Έκδοση: (2013-01-01)

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
ανά: Pratibha Singh, κ.ά.
Έκδοση: (2011-01-01)

The modern management of macroprolactinomas.
ανά: Grossman, A
Έκδοση: (1991)

Increased prevalence of high Body Mass Index in patients presenting with pituitary tumours: severe obesity in patients with macroprolactinoma
ανά: DL Goede, κ.ά.
Έκδοση: (2006-04-01)

Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction
ανά: Tania Sundra, κ.ά.
Έκδοση: (2024-03-01)

Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features.
ανά: Suliman, S, κ.ά.
Έκδοση: (2007)

No link to cardiac valvulopathy was seen in cabergoline treated patients
ανά: K Dharshini, κ.ά.
Έκδοση: (2012-10-01)

MANAGEMENT OF ENDOCRINE DISEASE: Pituitary tumour apoplexy.
ανά: Capatina, C, κ.ά.
Έκδοση: (2014)

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
ανά: Barber, T, κ.ά.
Έκδοση: (2011)

Reply to Commentary on "Pituitary apoplexy in an adolescent male with macroprolactinoma presenting as middle cerebral artery territory infarction"
ανά: Pankaj Agrawal, κ.ά.
Έκδοση: (2023-03-01)

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
ανά: Fernandez, A, κ.ά.
Έκδοση: (2010)

Macroprolactinoma in an adolescent female with primary amenorrhoea
ανά: Ning Zhang, κ.ά.
Έκδοση: (2024-12-01)